Concepedia

Robert A. Moye

RA

Statistics

Publications

5

Citations

150

H-Index

5

Active since

1994

Affiliations

University of Tennessee at Knoxville(Current)

University of Tennessee Medical Center

Robert A. Moye is an author at University of Tennessee at Knoxville specializing in pharmacy, pharmacotherapy, and primary outcome analysis.

Publications per year

1994–2021

5

Publications

5

Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease

Stefanie C. Sarratt, Ross M. Nesbit, Robert A. Moye · Annals of Pharmacotherapy · 2017 · 87 citations

, , +17

Use of Multiple-Dose Activated Charcoal in Phenytoin Toxicity

Carol E. Howard, R. Shane Roberts, Daniel S. Ely et al. · Annals of Pharmacotherapy · 1994 · 22 citations

, , +11

Tobramycin-Induced Hepatotoxicity

Sarah A. Nisly, Shaunta’ M. Ray, Robert A. Moye · Annals of Pharmacotherapy · 2007 · 14 citations

, , +13

Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis

Grace E. Cooksey, Jerry L. Epps, Robert A. Moye et al. · The Journal of Infectious Diseases · 2020 · 14 citations

, , +10

Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice model

Robert A. Moye, Kim Mason, Amy Flatt et al. · American Journal of Health-System Pharmacy · 2021 · 13 citations · Full text

, , +17

1–5 of 5